Abstract
This Frost & Sullivan research service entitled U.S. Ophthalmic
Pharmaceuticals Markets addresses patient dynamics and forecasts, product
analysis, competitor and pipeline analysis, and market revenue forecasts for
age-related macular degeneration (AMD), chronic dry eye, ocular allergy and
ocular NSAID markets.
This analysis is available through our Pharmaceutical & Biotechnology Growth
Partnership Services program. With this program, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.